Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Nichi-Iko Pharmaceutical Co Ltd
Cash from Operating Activities
Nichi-Iko Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
Cash from Operating Activities
-¥24.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Operating Activities
¥731.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Operating Activities
¥595.3B
|
CAGR 3-Years
47%
|
CAGR 5-Years
47%
|
CAGR 10-Years
25%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Operating Activities
¥283.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Operating Activities
¥409.9B
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
23%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Operating Activities
¥216.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
See Also
What is Nichi-Iko Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-24.2B
JPY
Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Cash from Operating Activities amounts to -24.2B JPY.
What is Nichi-Iko Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-43%